Biotech Stocks Moved Up During Its Last Trading Session -PATH, MNKD, INO, CVM
Pompano Beach, FL -- (SBWIRE) -- 01/18/2013 -- NuPathe Inc (NASDAQ:PATH) pleased to declare that its product Zecuity™for the acute treatment of migraine has been approved by the authority of U.S. Food and Drug Administration (FDA).
NuPathe Inc remained among bull of the day as it reported the rise of 14.93% and closed at $3.31 after gaining total volume of 2.70 million shares.
Company’s year to date performance remained quite pessimistic with the loss of -2.07% while in last 6 months it dropped almost -15.34%. During Last three months company reported a downward momentum of -3.78%. PATH has the total of 14.75 million outstanding shares and its total market capitalization is $48.84 million.
Has PATH Found The Bottom and Ready To Move Up? Find Out Here
Another biotech stock, MNKD which was moving upward, during its last trading session. MannKind Corporation (NASDAQ:MNKD) ended its day with a gaining stream and surged0.95%. Its shares closed at the price of $2.66after opening at $2.65.
During the previous session company’s minimum price was $2.63 while it touched its highest price for the day at $2.72. MNKD’s beta value stands at 1.06 points.
Stock traded during its last trading session with the total traded volume of 4.84 million shares as compared to its average volume of 2.70 million shares. During last one month company surged 21.46% while its last 5 days shows arise of 2.7%.
Why Should Investors Buy MNKD After The Recent Gain? Just Go Here and Find Out
Inovio Pharmaceuticals, Inc. (NYSE:INO) reported that the company along with its development partner VGX International, Inc. (KSE:011000)will move Inovio's hepatitis C (HCV) DNA vaccine into a phase I/IIa clinical trial by the end of this year.
The Biotech company has a positive moment of the day, as it Inovio Pharmaceuticals, Inc. (NYSE:INO) opened at the price of $0.68 whereas its previous closing price was recorded at $0.720. INO gained 7.46% and traded within the day range of $0.66 - $0.72 for the day, 52week range of the stock remained in between $0.38 - $0.90. Total volume of the stock was 3.53 million shares during last trade while its average volume is 1.31 million shares.
Company’s total market capitalization stands at $100.34 million along with 139.36 million outstanding shares.
Will INO Continue To Move Higher? Find Out Here
CEL-SCI has a positive moment of the day CEL-SCI Corporation (NYSE:CVM) reported the increase of 0.68% to close at $0.280with the overall traded volume of 5.60 million shares. Its market capitalization was $76.47 million. Its beta value stands at 2.09 times and earning per share was $-0.07.
CEL-SCI Corporation has the total of 273.21 million outstanding shares. During last trade company’s minimum price was $0.28 while it touched highest price of $0.28.
Where CVM is Headed Exactly? Find out in This Trend Analysis Reports
Company’s year to date performance remained quiet optimistic with the rise of 3.7%. If we look at last 6 months of trade that is in bearish zone with the plunge of -22.22%.
The TopStockPlays.com expert team is highly experienced in picking the low-priced shares with the biggest profit potential. We uncover the hidden gems in the stock market-shares that can break out for gains of 300%, 400%, even 500% within a few weeks.
PLEASE NOTE WELL: The TopStockPlays.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. Please do your research or consults your financial adviser before making any Investment decision. TopStockPlays.com or its employees will not be responsible for any loss or losses.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)